Bristol-Meyers Squibb to Close Wallingford Facility

Global biopharmaceutical company Bristol-Meyers Squibb has announced it will close its Wallingford CT facility in 2018. The closing is a part of a larger reorganization that includes expansion in Cambridge MA and San Francisco CA. 200 employees from BMS’ Wallingford and Waltham MA facilities will be relocated to its new Cambridge facility while 500 employees from Wallingford will be relocated to a facility elsewhere in CT. 

BMS Press Release: BMS News